These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 20466073)
1. Re: Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. Brenner SR Heart Rhythm; 2010 Jul; 7(7):e1; author reply e1-2. PubMed ID: 20466073 [No Abstract] [Full Text] [Related]
2. [Relationship between atrial fibrillation and other cardiovascular risk factors in Alzheimer's disease. New prevention opportunities]. Bellomo A; Mancinella M; Troisi G; Marigliano V Recenti Prog Med; 2009 Mar; 100(3):124-6. PubMed ID: 19475838 [TBL] [Abstract][Full Text] [Related]
3. Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score. Di Nisio M; Prisciandaro M; Rutjes AW; Russi I; Maiorini L; Porreca E Geriatr Gerontol Int; 2015 Jun; 15(6):770-7. PubMed ID: 25311856 [TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment (MCI). Forti P; Maioli F; Pisacane N; Rietti E; Montesi F; Ravaglia G Arch Gerontol Geriatr; 2007; 44 Suppl 1():155-65. PubMed ID: 17317449 [TBL] [Abstract][Full Text] [Related]
5. Factors associated with undertreatment of atrial fibrillation in geriatric outpatients with Alzheimer disease. Tavassoli N; Perrin A; Bérard E; Gillette S; Vellas B; Rolland Y; Am J Cardiovasc Drugs; 2013 Dec; 13(6):425-33. PubMed ID: 23943094 [TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. Bunch TJ; Weiss JP; Crandall BG; May HT; Bair TL; Osborn JS; Anderson JL; Muhlestein JB; Horne BD; Lappe DL; Day JD Heart Rhythm; 2010 Apr; 7(4):433-7. PubMed ID: 20122875 [TBL] [Abstract][Full Text] [Related]
7. [Vascular risk factors in demented elderly: analysis of Alzheimer Clinic materials]. Czyzewski K; Pfeffer A; Wasiak B; Łuczywek E; Gołebiowski M; Styczyńska M; Barcikowska M Neurol Neurochir Pol; 2001; 35(3):405-13. PubMed ID: 11732264 [TBL] [Abstract][Full Text] [Related]
8. Association between new-onset atrial fibrillation and dementia among individuals with type 2 diabetes. Zhou Y; Xu M; Yin X; Gong Y Diabetes Obes Metab; 2024 Sep; 26(9):3715-3722. PubMed ID: 38874105 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. Hu D; Sun Y J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352 [No Abstract] [Full Text] [Related]
10. Public health importance of vascular dementia and Alzheimer's disease with cerebrovascular disease. Bennett D Int J Clin Pract Suppl; 2001 May; (120):41-8. PubMed ID: 11406925 [TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation. Liew A; Eikelboom JW; O'Donnell M Curr Opin Cardiol; 2012 Jul; 27(4):331-9. PubMed ID: 22573171 [TBL] [Abstract][Full Text] [Related]
12. Patterns of anticoagulation in patients hospitalized with atrial fibrillation: warfarin is underused in paroxysmal atrial fibrillation. Marcu CB; Ghantous AE; Caracciolo EA; Donohue TJ Conn Med; 2003; 67(10):595-8. PubMed ID: 14677339 [TBL] [Abstract][Full Text] [Related]
13. The management of anticoagulants in the periendoscopic period for patients with atrial fibrillation: a decision analysis. Gerson LB; Triadafilopoulos G; Gage BF Am J Med; 2004 Apr; 116(7):451-9. PubMed ID: 15047034 [TBL] [Abstract][Full Text] [Related]
14. The CHADS2 score for stroke risk stratification in atrial fibrillation--friend or foe? Karthikeyan G; Eikelboom JW Thromb Haemost; 2010 Jul; 104(1):45-8. PubMed ID: 20458437 [No Abstract] [Full Text] [Related]
15. Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspective. Chevalier J; Delaitre O; Hammès F; de Pouvourville G Arch Cardiovasc Dis; 2014; 107(6-7):381-90. PubMed ID: 24973113 [TBL] [Abstract][Full Text] [Related]
16. Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia. Jacobs V; Woller SC; Stevens S; May HT; Bair TL; Anderson JL; Crandall BG; Day JD; Johanning K; Long Y; Mallender C; Olson JL; Osborn JS; Weiss JP; Bunch TJ Heart Rhythm; 2014 Dec; 11(12):2206-13. PubMed ID: 25111326 [TBL] [Abstract][Full Text] [Related]
17. Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials. Renda G; di Nicola M; De Caterina R Am J Med; 2015 Sep; 128(9):1007-14.e2. PubMed ID: 25910790 [TBL] [Abstract][Full Text] [Related]
18. Newer anticoagulants as an alternate to warfarin in atrial fibrillation: a changing paradigm. Chaudhari D; Bhuriya R; Arora R Am J Ther; 2011 Jan; 18(1):e1-e11. PubMed ID: 20460986 [TBL] [Abstract][Full Text] [Related]
19. [Frequency of use of oral vitamin K antagonists in patients with atrial fibrillation and cognitive function disturbances]. Gorzelak P; Zyzak S; Krewko Ł; Mozdzan M; Broncel M Pol Merkur Lekarski; 2014 May; 36(215):302-6. PubMed ID: 24964505 [TBL] [Abstract][Full Text] [Related]
20. Stroke prevention in atrial fibrillation: do we still need warfarin? Diener HC; Weber R; Lip GY; Hohnloser SH Curr Opin Neurol; 2012 Feb; 25(1):27-35. PubMed ID: 22143201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]